Considering the overall staining of tumor and matched normal pancreatic samples, we found that almost all samples stained positive for TRAIL-R2; instead, TRAIL-R1 stained negative in 23% of tumor samples and in 11% of matched normal pancreatic samples. Here, TNFRSF10A is linked to neoplasm.